Decision SystemDecision 2 of 6

PE-backed manufacturer

Capital should not be deployed merely because it is available

A premium manufacturer considering up to €25m in new fund equity, subject to approval, with an exit expected within four years.

An illustrative scenario. It does not describe a client or a real company.

Frame

Objective, horizon, non-negotiables and who holds authority.

The private-equity fund is prepared to provide its portfolio company with up to €25 million in additional equity, subject to investment approval. This is not existing company cash. The fund expects to exit within four years.

Availability does not oblige the fund to invest. This comparison models a fixed €25m equity contribution if approved. Partial deployment and a separate no-investment alternative are not simulated.

Management prefers organic investment. The board likes the acquisition because it changes the equity story immediately.

The three proposed uses of new equity

  • Acquire a smaller competitor for €25m in purchase consideration plus €2m in integration costs. It brings immediate market share and US distribution, but valuation, customer concentration and founder dependence are material risks. Funding beyond the proposed equity contribution requires additional financing, subject to borrowing capacity and covenants.
  • Invest organically in production modernisation, two new products and a US commercial team. Returns take longer and the market window may narrow.
  • Contribute new fund equity to reduce outstanding company debt and strengthen the balance sheet. The contribution is invested, not held as cash for a later opportunity.

Which option creates transferable, defensible value within the ownership horizon, and which merely produces the appearance of action?

Objective
Create value that a buyer will pay for at exit, and that does not leave with any one person.
Horizon
Four years to exit.
Non-negotiables
  • Covenants are not put at risk to fund an equity story.
  • No commitment is made on evidence that does not yet exist.
Who decides
Board and investment committee. Management recommends. Commitment of the capital is not management’s decision.

Observe

What is established, what is assumed and what is missing.

Starting brief, before any controls are changed. Every item is typed. Facts come from the fictional scenario. Assumptions are illustrative quantities added so the consequences can be calculated. Unknowns are left unknown.

Established 4

  • Fact:

    The fund is prepared to provide up to €25m in additional equity, subject to investment approval. It is not existing company cash and need not be deployed merely because it is available. The fund expects to exit within 4 years.

    Given in the scenario. High confidence.

  • Fact:

    The target brings market share and US distribution. Its valuation is high, customer concentration is material and it depends on its founder.

    Given in the scenario. High confidence.

  • Fact:

    The organic plan is production modernisation, 2 new products and a US commercial team. Returns take longer and the market window may narrow.

    Given in the scenario. High confidence.

  • Fact:

    Management prefers organic investment. The board prefers the acquisition.

    Given in the scenario. High confidence.

Assumed 7

  • Assumption:

    EBITDA of €18m, net debt of €60m at 8.5%, a leverage covenant of 4x and an exit multiple of 9x.

    Illustrative modelling assumption. Medium confidence.

  • Assumption:

    The target earns €3.6m EBITDA and is priced at €25m, with €2m of integration cost. 45% of its revenue rests on the founder’s relationships. Its top 3 customers are 55% of revenue.

    Illustrative modelling assumption. Low confidence.

  • Assumption:

    Untested, 50% of founder-dependent revenue is assumed to leave with the founder. If transfer is demonstrated, 10%. If it is not transferable, 80%.

    Illustrative modelling assumption. Low confidence.

  • Assumption:

    The organic plan adds €4.5m EBITDA at maturity after 3 years. Without differentiation it achieves 30% of that.

    Illustrative modelling assumption. Low confidence.

  • Assumption:

    The comparisons assume approval of a fixed €25m new equity contribution. Starting net debt is measured before it; the contribution is not cash already deducted from net debt. The return reference leaves the proposed capital with the fund and assigns it no return. That reference is not a selectable no-investment alternative; partial allocations are not modelled.

    Illustrative modelling assumption. Low confidence.

  • Assumption:

    Illustrative cash conversion of EBITDA after tax, maintenance investment and working capital is 60%. The tax rate is 25%. Additional acquisition financing is modelled as debt at the company debt rate, subject to borrowing capacity, covenants and lender approval. Retained cash earns no return. No synergies or exit-multiple expansion are assumed.

    Illustrative modelling assumption. Low confidence.

  • Assumption:

    Customer-level diligence on transferability takes about 90 days.

    Illustrative modelling assumption. Medium confidence.

Not yet known 4

  • Unknown:

    Whether the target’s customer relationships transfer once the founder leaves.

    Given in the scenario. Low confidence.

  • Unknown:

    Whether there is unmet demand, and a durable reason the new products can win.

    Given in the scenario. Low confidence.

  • Unknown:

    The depth and independence of the target’s management team.

    Given in the scenario. Low confidence.

  • Unknown:

    Whether the organisation can execute the organic plan, and how quickly it reaches value.

    Given in the scenario. Low confidence.

Model

The relationships that can be calculated, and their limits.

Only relationships that can honestly be calculated are modelled. Apply one bounded pressure, or move one assumption, and follow the consequence across the organisation.

Apply one pressure
45%

Bounded to 15% to 75%.

Apply a pressure to see what moves, in what order, and where it stops.

Contest

Functional positions, conflict and a critic.

Each function answers in the same structure: a recommendation, the evidence it rests on, the assumption underneath, its confidence, the consequence for another function and the authority it would need. These positions and qualitative findings were authored in advance; the calculations and evidence ranking respond to the current state.

The functional positions

Governance

Argues for: acquire the competitor

Acquire. Market share and US distribution arrive on day one, inside the hold of 4 years. Organic returns arrive late.

Rests on
  • Fact:The fund is prepared to provide up to €25m in additional equity, subject to investment approval. It is not existing company cash and need not be deployed merely because it is available. The fund expects to exit within 4 years.
    Current model: New equity contribution modelled if approved: €25.0m; Years to exit: 4 years
  • Fact:The target brings market share and US distribution. Its valuation is high, customer concentration is material and it depends on its founder.
  • Fact:Management prefers organic investment. The board prefers the acquisition.
    Current model: Time allowed for the decision: 180 days
Assumes
A buyer at exit pays 9.0x for the acquired earnings as readily as for the core.
Consequence for finance
Test the exit case on retained earnings of €2.8m, not the reported figure.
Medium confidenceHuman decision required

Finance

Argues against: acquire the competitor

Do not commit to the acquisition yet. The headline multiple is 6.9x. On retained target EBITDA it is 9.7x, and incremental equity is €4.3m, with €2.0m extra debt required.

Rests on
  • Fact:The target brings market share and US distribution. Its valuation is high, customer concentration is material and it depends on its founder.
  • Assumption:The target earns €3.6m EBITDA and is priced at €25m, with €2m of integration cost. 45% of its revenue rests on the founder’s relationships. Its top 3 customers are 55% of revenue.
    Current model: Target EBITDA: €3.6m; Acquisition price: €25.0m; Integration cost: €2.0m; Target revenue resting on the founder: 45%; Top three customers, share of target revenue: 55%
  • Assumption:Untested, 50% of founder-dependent revenue is assumed to leave with the founder. If transfer is demonstrated, 10%. If it is not transferable, 80%.
    Current model: Founder-dependent revenue assumed lost: 50%
Assumes
50% of founder-dependent revenue leaves with the founder.
Consequence for commercial
Customer-by-customer retention evidence would replace this assumption with a fact.
Medium confidenceRecommend

Commercial

Conditionally for: invest organically

Organic wins only if the two products have a reason to win. Today that is conviction, not evidence. Test it before committing.

Rests on
  • Fact:The organic plan is production modernisation, 2 new products and a US commercial team. Returns take longer and the market window may narrow.
  • Unknown:Whether there is unmet demand, and a durable reason the new products can win.
    Current model: Evidence of differentiation: Not yet tested
Assumes
The market window stays open for 3 years.
Consequence for finance
The organic case ranges from −€10.4m to €23.6m. Plan on neither.
Low confidenceRecommend

Operations

Conditionally for: invest organically

Modernisation, two launches and a US team are three programmes on one management team. An acquisition would add integration as a fourth.

Rests on
  • Fact:The organic plan is production modernisation, 2 new products and a US commercial team. Returns take longer and the market window may narrow.
  • Unknown:Whether the organisation can execute the organic plan, and how quickly it reaches value.
Assumes
Current leaders can carry one major programme beyond running the business.
Consequence for governance
Whichever option is chosen, sequence it. The plan as written assumes attention that does not exist.
Medium confidenceRecommend

Calculated

Total acquisition funding required

€27.0m

The full amount to fund.

Calculated

Additional acquisition debt required

€2.0m

A funding requirement, not extra equity capital silently assumed available.

Calculated

Acquisition incremental equity at exit

€4.3m

Includes operating cash, purchase and integration costs, and additional financing cost; new equity is funding, not created value.

Assumption: Assumption carrying weight

Untested, 50% of founder-dependent revenue is assumed to leave with the founder. If transfer is demonstrated, 10%. If it is not transferable, 80%.

Low confidence. If this is wrong, the calculations that rest on it move with it.

Unknown: First in current evidence ranking

Whether the target’s customer relationships transfer once the founder leaves.

The answer could be “relationships demonstrably transfer” or “relationships stay with the founder”. They lead to different decisions, which makes this decision-relevant evidence.

Unknown: Further evidence to investigate

Whether there is unmet demand, and a durable reason the new products can win.

The answer could be “differentiation is evidenced” or “the segment is saturated”. They lead to different decisions, which makes this decision-relevant evidence.

Authority gate

Transferability is not demonstrated

Commitment of capital and any acquisition go to the board or investment committee.

Human decision required

The critic

Authored findings challenge the positions. Rule checks and the calculated evidence priority are labelled separately.

  • Contradiction between functions · rule checkGovernance, Finance

    Governance and Finance take opposite sides on "Acquire the competitor". Both cannot be followed.

  • Unsupported certainty · authoredGovernance

    The equity story values the target at €7.4m of created value. It assumes every customer stays when the founder leaves. Nothing in evidence supports that.

  • Omitted second-order effect · authoredGovernance, Operations

    Operations identifies competing demands on the leadership team. Capacity for integration and the organic programmes is still unverified.

  • Omitted second-order effect · authoredFinance

    Total funding is €27.0m, including €2.0m beyond the envelope. Lender approval is not established; the funding requirement must be confirmed before commitment.

  • False precision · authoredCommercial, Finance

    Organic value runs from −€10.4m to €23.6m. The midpoint of a range that wide is not an estimate.

  • Priority missing evidence · calculatedGovernance

    Whether the target’s customer relationships transfer once the founder leaves. Its possible answers change the rule-based conclusion in this state.

Where that leaves the room

Agreed

  • Nobody disputes that the target depends on its founder, or that the capital should create value a buyer will pay for.

Still in dispute

  • Governance and Finance. Whether the acquisition creates value. The board counts reported earnings. Finance counts what stays.

Not for analysis to decide

  • Commitment of capital and any acquisition belong to the board or investment committee. Analysis can normalise diligence, test valuation, model scenarios and name the evidence gaps.

The disagreements are kept. Someone accountable has to choose between them.

Decide

Options, trade-offs and an accountable call.

Three credible courses of action. Each one is carried by assumptions that would need to be true. Choose the one you would take. Your choice is not scored.

Choose a course of action

Current result from authored decision rules

Not the acquisition as it stands. Between the other two, the evidence decides.

Customer transferability remains unverified or adverse. Organic investment against debt reduction turns on differentiation, which remains untested. Total acquisition funding is €27.0m, including €2.0m integration; €2.0m exceeds the capital envelope and is modelled as additional debt.

Christianna’s authored starting judgement, unchanged by the controls

Not the acquisition as it stands. Organic investment or debt reduction, decided by evidence.

Organic investment is justified only if there is credible evidence of market space and a defensible reason the products can win.

Innovation may come from product, business model, channel, experience, brand, pricing or cost structure. It need not be technological.

If the company would simply add undifferentiated capacity to a saturated market, I reduce debt and preserve optionality.

Rejected
Pursuing the acquisition before founder dependence has been separated from durable company value.
The assumption carrying it
That the value being bought sits in the company and not in its founder.
Authority I keep
Capital commitment and acquisition sit with the investment committee or board.
What I would delegate to AI
Normalising diligence, testing valuation assumptions, modelling scenarios and identifying evidence gaps.
What would change my mind
The acquisition becomes viable if the valuable relationships and capabilities are demonstrably transferable and the economics remain attractive after realistic retention and integration assumptions. Organic investment becomes viable when market differentiation and execution capability are evidenced.

Do not confuse pressure to deploy capital with evidence that capital should be deployed.

Christianna Hamilton

This is one accountable judgement for the stated objective and evidence. It is not offered as the universal answer.

Act

Bounded actions, owners and approvals.

You have not selected a course of action.

Current result from authored decision rules: Not the acquisition as it stands. Between the other two, the evidence decides. Customer transferability remains unverified or adverse. Organic investment against debt reduction turns on differentiation, which remains untested. Total acquisition funding is €27.0m, including €2.0m integration; €2.0m exceeds the capital envelope and is modelled as additional debt.

Action plan accompanying the authored starting judgement

This plan belongs to the original written judgement below. It does not represent execution of your selection or a newly generated action plan.

First action

Commission the evidence that decides it: customer-level transferability at the target, and market space for the two products.

Measure to watch

Exit-value sensitivity under each option, as the evidence arrives.

  1. Establish whether customer relationships transfer after the founder leaves.

    CommercialPrepare for approval

  2. Assess the depth and independence of the acquired management team.

    OperationsPrepare for approval

  3. Test customer concentration and retention sensitivity.

    RiskDraft

  4. Find evidence of unmet demand or market whitespace.

    CommercialPrepare for approval

  5. Establish product differentiation and how long it is likely to last.

    CommercialPrepare for approval

  6. Assess organic execution capacity and time to value.

    OperationsRecommend

  7. Set out debt cost, covenant headroom and the value of resilience.

    FinanceDraft

  8. Model exit-value sensitivity under each option.

    FinanceDraft

Where calculation ends and human authority begins
  1. Calculate and surface. Evidence, assumptions, arithmetic and consequences are made visible.
  2. Investigate and challenge. AI can extend the search, prepare options and test for conflict or unsupported certainty.
  3. Decide and own. An accountable person weighs the trade-offs, makes the call and remains responsible for what follows.

Learn

What would show the judgement was wrong.

Hypothetical counterfactual evidence. Change one material condition and compare the result below. This experiment does not replace the working state in Model, Contest, Decide or Act.

Change one condition

Method and provenance

The scenario is illustrative. It does not describe a client, an engagement or a real company.

What the tools do, and what remains human

  • Calculate and surface. Arithmetic and thresholds are handled consistently so the same inputs produce the same result.
  • Investigate and challenge. Functional positions expose disagreement. The critic looks for conflict, missing evidence, double counting and unsupported certainty. A live reading, where offered, can extend that challenge but cannot alter the underlying numbers or the signed decision.
  • Decide and own. The signed judgement is Christianna Hamilton’s. It is written in advance and remains the responsibility of a person, not a system.

Evidence

Items marked given in the scenario come from the written brief. Items marked illustrative modelling assumption are quantities added so that consequences can be calculated. Evidence last reviewed 2026-09-21.

Calculations in this decision

QuantityUnitWhat it assumes
Total acquisition funding requiredEUR millionPurchase price plus integration, both paid at the start.
Additional acquisition debt requiredEUR millionAmount above the proposed €25m new equity contribution; modelled as additional debt subject to borrowing capacity, covenants and lender approval.
Leverage after acquisition fundingmultipleExisting debt plus funding gap divided by combined retained EBITDA.
Additional funding interest after taxEUR millionFunding gap held for the full horizon, simple interest after tax.
Acquisition cash retained during holdEUR millionRetained EBITDA at a constant level, converted to cash after tax, maintenance and working capital.
LeveragemultipleNet debt over EBITDA.
Covenant headroommultipleCovenant less current leverage.
Founder-dependent revenue lostper cent10% if transfer is demonstrated, 80% if not transferable, otherwise the untested assumption.
Target earnings at riskEUR millionEarnings follow revenue proportionally.
Target earnings retainedEUR millionNone beyond its inputs.
Headline price multiplemultiplePrice over reported EBITDA.
Effective price multiplemultiplePrice plus integration over retained EBITDA.
Headline terminal-only surplus, not the full returnEUR millionEvery customer stays. No integration cost.
Acquisition incremental equity at exitEUR millionExit enterprise value plus retained cash, less total purchase and integration cost and incremental financing interest. Increment versus leaving the proposed capital uninvested with the fund, not NPV. The new equity contribution is funding, not value created.
Organic incremental equity at exitEUR millionYear-end linear EBITDA ramp, retained cash after tax and reinvestment, terminal enterprise value less initial investment. Same uninvested-fund-capital reference as acquisition and debt reduction; that reference is not a selectable alternative.
Organic incremental equity without differentiationEUR millionSame cash and terminal-value calculation, reduced to the undifferentiated share.
Debt reduction incremental equity at exitEUR millionDebt repaid up to outstanding debt. Simple interest saved after tax is retained as cash. Principal reduction offsets cash spent, so principal is not counted again as created value.
Leverage after paydownmultipleThe approved €25m equity contribution repays debt, capped at the amount outstanding.
Days by which the deadline precedes the evidencedaysDiligence cannot be compressed.